Skip to content

Can a vertebral fracture screening tool be used remotely as well as face-to-face?

Testing an osteoporotic vertebral fracture screening tool (Vfrac): remote vs face-to-face data collection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN12150779
Enrollment
120
Registered
2022-01-10
Start date
2022-05-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporotic vertebral fractures Musculoskeletal Diseases Osteoporosis with pathological fracture

Interventions

Stage 1: Testing agreement between remote vs face-to-face (F2F) Vfrac in men Men aged over 65 years (65+) who have had a spinal radiograph will be invited to take part in this study. All those recruit

Sponsors

University of Bristol
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Stage 1: 1. Patient is willing and able to give informed consent for participation in the study 2. Male aged 65+ years 3. Spinal radiograph in the previous 3 to 6 months Stage 2: 1. Patient is willing and able to give informed consent for participation in the study 2. Patient had a previous F2F use of Vfrac when consulting in primary care with back pain

Exclusion criteria

Exclusion criteria: Stage 1: 1. Female 2. Aged under 65 years 3. Has not had a spinal radiograph in the previous 3 to 6 months 4. Spinal malignancy (cancer) mentioned in the radiology report 5. Patients who do not have the capacity to provide informed consent. Capacity to consent will be assessed by the researcher, in consultation with a clinical member of the study team (EC). This is in accordance with the Mental Capacity Act 2005 (https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/mental-capacity-act/). 6. Participants who are unwilling to provide informed consent Stage 2: 1. Not had a previous F2F use of Vfrac 2. Spinal malignancy 3. Patients who do not have the capacity to provide informed consent. Capacity to consent will be assessed by the researcher, in consultation with a clinical member of the study team (EC). This is in accordance with the Mental Capacity Act 2005 (https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/mental-capacity-act/) 4. Participants who are unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
Measures taken once in each stage: Stages 1 and 2: 1. Risk of having an osteoporotic vertebral fracture (OVF) as calculated by the self-completed Vfrac tool 2. Risk of having an OVF as calculated by the face-to-face Vfrac tool Stage 3: Assessment of agreement between remote vs F2F use of the Vfrac tool using Cohen’s kappa. Standard classifications of Cohen’s kappa will be used with 0.6 indicating substantial agreement

Secondary

MeasureTime frame
Satisfaction and ease of use of remote vs F2F Vfrac questionnaire collected during Stages 1 and 2. Questions based on the framework on Quality in Healthcare developed by Huycke et al. to cover process, interpersonal and technical attributes, plus relevant questions from the validated question on remote consultations by Mekhjian et al.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026